# Tirzepatide in Inflammatory Bowel Disease: Steroid Use Against the GLP-1 Class

A retrospective IBD study compared intravenous steroid use, bowel surgery and other outcomes after tirzepatide or other GLP-1 prescriptions.

Publisher: Buy This GLP Editorial Team
Canonical: https://buythisglp.com/research/tirzepatide-inflammatory-bowel-disease
Updated: 2026-11-15
Published: 2026-09-16

[← Research](https://buythisglp.com/research)

Evidence

# Tirzepatide in Inflammatory Bowel Disease: Steroid Use Against the GLP-1 Class

In a matched U.S. cohort with inflammatory bowel disease, tirzepatide prescriptions were associated with less intravenous steroid use than other GLP-1 prescriptions.

Editorial profile: [Wesley Jenkins](https://buythisglp.com/authors/wesley-jenkins)[Buy This GLP Editorial Team](https://buythisglp.com/about)September 20266 min readUpdated November 2026

Tirzepatide vs other GLP-1 drugs, adjusted hazard ratio · 1.0 · IV steroids · 0.81 · composite IBD outcome · 0.86 · 3,042 per matched cohort. No clear difference in surgery or hospitalization.

**Research, not medical advice.** Buy This GLP is independent and educational. Nothing here is a substitute for individualized care from a licensed clinician, and reading it creates no doctor–patient relationship. Talk to your own provider before starting, stopping, or changing any medication, peptide, or therapy. See our [methodology](https://buythisglp.com/methodology) and [terms](https://buythisglp.com/terms).

In the [tirzepatide cardiovascular trial](https://buythisglp.com/research/is-tirzepatide-good-for-your-heart), researchers assigned two named drugs. This separate bowel disease study compared prescriptions from medical records, with several GLP-1 drugs grouped into one comparator [\[1\]](https://buythisglp.com/research/tirzepatide-inflammatory-bowel-disease#ref-1).

## What the records showed

Researchers matched 3,042 adults with inflammatory bowel disease in each group. Median follow-up was 540 days. Tirzepatide was associated with a lower hazard of intravenous steroid use (adjusted hazard ratio 0.81, 95% CI 0.68 to 0.94) [\[1\]](https://buythisglp.com/research/tirzepatide-inflammatory-bowel-disease#ref-1).

The adjusted hazard ratio for the combined IBD outcome was 0.86 (95% CI 0.73 to 0.97). Hospitalization, emergency visits and bowel surgery did not show statistically clear differences.

## What the comparison can establish

The records compare prescribing groups. Database matching cannot account for all differences in disease activity or why a clinician chose a drug. The study cannot establish that tirzepatide treats inflammatory bowel disease or that it improves outcomes versus a specific GLP-1 drug.

## Frequently asked

Did the study find less bowel surgery with tirzepatide?

It found no statistically clear difference for surgery. The clearest association was with intravenous steroid use.

## Sources

1.  \[1\] Patel KS, et al. (2026). Comparative outcomes for tirzepatide versus glucagon-like peptide-1 receptor agonists in patients with inflammatory bowel disease: a national propensity matched study Intestinal Research. [PMID 42717572](https://doi.org/10.5217/ir.2026.00152)

## Where to get it

### Price the injectable sellers

The desk lists every seller that publishes an injectable figure, with the advertised price struck against the one a buyer is billed.

[Open the price desk →](https://buythisglp.com/)

## More in Evidence

-   [
    
    50,678 adults with a BMI of 30 or more · Prescribed · 8.0% · Filled · 4.4% · Outlined bar runs to 10%. Medicaid had lower odds of both.
    
    ### Does Medicaid Cover Weight Loss Drugs? It Depends on Your State
    
    ](https://buythisglp.com/research/does-medicaid-cover-weight-loss-drugs)
-   [
    
    What the claim rests on · Sleep study · AHI 15 or more · Obesity · BMI 30 or more · Prescription · for sleep apnea · Part D claim · plan review · Trial thresholds shown. Your plan sets its approval requirements.
    
    ### Does Medicare Cover Zepbound for Sleep Apnea? The Diagnosis Is the Key
    
    ](https://buythisglp.com/research/does-medicare-cover-zepbound-for-sleep-apnea)
-   [
    
    Illustrative decline with a one-week half-life · Ozempic window: up to 5 days late · 100% · day 0 · 82% · day 2 · 67% · day 4 · 61% · day 5 · 50% · day 7 · A calculation from the label half-life, not a blood test.
    
    ### What Happens If You Miss a Dose of Ozempic? A Week-Long Half-Life Buys Time
    
    ](https://buythisglp.com/research/what-happens-if-you-miss-a-dose-of-ozempic)
